Please assess the completion status of the following clinical trial:

Trial Title: Involuntary Memories Investigation in Schizophrenia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* - for patients only~* male or female~* age limits : 18-55 years old~* under the protection of health insurance~* who have signed up the consent form~* schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA, 2013).~* clinically stable for at least 2 months~* patients under guardianship or curatorship need agreement of their legal representative~* informed of the results of prior medical examination for controls only~* male or female~* age limits : 18-55 years old~* under the protection of health insurance~* who have sign up the consent form~* recruited from the general population and matched on gender, age years of schooling~* no psychiatric history (DSM-5)~Exclusion Criteria:~* for both patients and controls~* current severe or unstable somatic illness~* neurological history (brain injury \> 15 minutes loss of consciousness , epilepsia, brain surgery...)~* current substance use disorder (DSM-5)~* current major depressive disorder (CDSS,BDI, HDRS)~* mental retardation (IQ \< 70, WAIS-4, f-NART)~* history of general anesthesia 3 months prior to the experiment~* pregnancy declared by the subject~* breast feeding~* current legal control~* in emergency situation~* included during exclusion period in another experiment~* for controls only~* taking of antipsychotic drugs for the 3 weeks prior to inclusion~* under guardianship or curatorship

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Control group (Type: ACTIVE_COMPARATOR): Control participants without psychiatric nor neurological history
- Patients with Schizophrenia (Type: EXPERIMENTAL): Patients with schizophrenia or schizoaffective disorder according to DSM-V criteria

Based on this trial design, predict the completion outcome and termination type (if applicable).